Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study

Author:

Griffith David E.1,Eagle Gina2,Thomson Rachel3ORCID,Aksamit Timothy R.4,Hasegawa Naoki5,Morimoto Kozo6,Addrizzo-Harris Doreen J.7,O’Donnell Anne E.8,Marras Theodore K.9,Flume Patrick A.10,Loebinger Michael R.11,Morgan Lucy12,Codecasa Luigi R.13,Hill Adam T.14,Ruoss Stephen J.15,Yim Jae-Joon16,Ringshausen Felix C.17,Field Stephen K.18,Philley Julie V.1,Wallace Richard J.1,van Ingen Jakko19,Coulter Chris20,Nezamis James2,Winthrop Kevin L.21

Affiliation:

1. The University of Texas Health Science Center at Tyler, Tyler, Texas

2. Insmed Incorporated, Bridgewater, New Jersey

3. University of Queensland, Gallipoli Medical Research Institute, Brisbane, Queensland, Australia

4. Pulmonary Disease and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota

5. Keio University Hospital, Tokyo, Japan

6. Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan

7. Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, New York

8. Division of Pulmonary, Critical Care and Sleep Medicine, Georgetown University Hospital, Washington, District of Columbia

9. Department of Medicine, University of Toronto, and Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

10. Medical University of South Carolina, Charleston, South Carolina

11. Host Defense Unit, Royal Brompton Hospital, and Imperial College, London, United Kingdom

12. Concord Clinical School, University of Sydney, Sydney, New South Wales, Australia

13. TB Reference Centre, Villa Marelli Institute/Niguarda Hospital, Milan, Italy

14. Department of Respiratory Medicine, Royal Infirmary of Edinburgh and Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom

15. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California

16. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

17. Department of Respiratory Medicine, Hannover Medical School, and German Center for Lung Research, Hannover, Germany

18. Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

19. Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands

20. Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Brisbane, Australia; and

21. OHSU-PSU School of Public Health, Portland, Oregon

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3